Researchers are investigating the clumping behavior of peptides, which are short chains of amino acids, to better understand their potential in drug development and material science. Peptide aggregation is often linked to diseases like Alzheimer’s, but it can also be harnessed for creating new materials. By studying these processes, scientists aim to develop more effective therapies and innovative materials with unique properties.
For more details, you can view the full article here: